Literature DB >> 26758213

Allosteric signaling through an mGlu2 and 5-HT2A heteromeric receptor complex and its potential contribution to schizophrenia.

José L Moreno1, Patricia Miranda-Azpiazu2, Aintzane García-Bea3, Jason Younkin4, Meng Cui4, Alexey Kozlenkov5, Ariel Ben-Ezra5, Georgios Voloudakis5, Amanda K Fakira6, Lia Baki4, Yongchao Ge7, Anastasios Georgakopoulos5, José A Morón6, Graeme Milligan8, Juan F López-Giménez9, Nikolaos K Robakis10, Diomedes E Logothetis4, J Javier Meana11, Javier González-Maeso12.   

Abstract

Heterotrimeric guanine nucleotide-binding protein (G protein)-coupled receptors (GPCRs) can form multiprotein complexes (heteromers), which can alter the pharmacology and functions of the constituent receptors. Previous findings demonstrated that the Gq/11-coupled serotonin 5-HT2A receptor and the Gi/o-coupled metabotropic glutamate 2 (mGlu2) receptor-GPCRs that are involved in signaling alterations associated with psychosis-assemble into a heteromeric complex in the mammalian brain. In single-cell experiments with various mutant versions of the mGlu2 receptor, we showed that stimulation of cells expressing mGlu2-5-HT2A heteromers with an mGlu2 agonist led to activation of Gq/11 proteins by the 5-HT2A receptors. For this crosstalk to occur, one of the mGlu2 subunits had to couple to Gi/o proteins, and we determined the relative location of the Gi/o-contacting subunit within the mGlu2 homodimer of the heteromeric complex. Additionally, mGlu2-dependent activation of Gq/11, but not Gi/o, was reduced in the frontal cortex of 5-HT2A knockout mice and was reduced in the frontal cortex of postmortem brains from schizophrenic patients. These findings offer structural insights into this important target in molecular psychiatry.
Copyright © 2016, American Association for the Advancement of Science.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26758213      PMCID: PMC4819166          DOI: 10.1126/scisignal.aab0467

Source DB:  PubMed          Journal:  Sci Signal        ISSN: 1945-0877            Impact factor:   8.192


  70 in total

1.  Structures of the CXCR4 chemokine GPCR with small-molecule and cyclic peptide antagonists.

Authors:  Beili Wu; Ellen Y T Chien; Clifford D Mol; Gustavo Fenalti; Wei Liu; Vsevolod Katritch; Ruben Abagyan; Alexei Brooun; Peter Wells; F Christopher Bi; Damon J Hamel; Peter Kuhn; Tracy M Handel; Vadim Cherezov; Raymond C Stevens
Journal:  Science       Date:  2010-10-07       Impact factor: 47.728

2.  Metabotropic glutamate mGlu2 receptor is necessary for the pharmacological and behavioral effects induced by hallucinogenic 5-HT2A receptor agonists.

Authors:  José L Moreno; Terrell Holloway; Laura Albizu; Stuart C Sealfon; Javier González-Maeso
Journal:  Neurosci Lett       Date:  2011-01-27       Impact factor: 3.046

3.  Heterocomplex formation of 5-HT2A-mGlu2 and its relevance for cellular signaling cascades.

Authors:  Hannah K Delille; Judith M Becker; Sabrina Burkhardt; Barbara Bleher; Georg C Terstappen; Martin Schmidt; Axel H Meyer; Liliane Unger; Gerard J Marek; Mario Mezler
Journal:  Neuropharmacology       Date:  2012-01-25       Impact factor: 5.250

4.  Decoding the signaling of a GPCR heteromeric complex reveals a unifying mechanism of action of antipsychotic drugs.

Authors:  Miguel Fribourg; José L Moreno; Terrell Holloway; Davide Provasi; Lia Baki; Rahul Mahajan; Gyu Park; Scott K Adney; Candice Hatcher; José M Eltit; Jeffrey D Ruta; Laura Albizu; Zheng Li; Adrienne Umali; Jihyun Shim; Alexandre Fabiato; Alexander D MacKerell; Vladimir Brezina; Stuart C Sealfon; Marta Filizola; Javier González-Maeso; Diomedes E Logothetis
Journal:  Cell       Date:  2011-11-23       Impact factor: 41.582

5.  A multicenter, inpatient, phase 2, double-blind, placebo-controlled dose-ranging study of LY2140023 monohydrate in patients with DSM-IV schizophrenia.

Authors:  Bruce J Kinon; Lu Zhang; Brian A Millen; Olawale O Osuntokun; Judy E Williams; Sara Kollack-Walker; Kimberley Jackson; Ludmila Kryzhanovskaya; Natalia Jarkova
Journal:  J Clin Psychopharmacol       Date:  2011-06       Impact factor: 3.153

6.  Crystal structure of the µ-opioid receptor bound to a morphinan antagonist.

Authors:  Aashish Manglik; Andrew C Kruse; Tong Sun Kobilka; Foon Sun Thian; Jesper M Mathiesen; Roger K Sunahara; Leonardo Pardo; William I Weis; Brian K Kobilka; Sébastien Granier
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

7.  Crystal structure of the β2 adrenergic receptor-Gs protein complex.

Authors:  Søren G F Rasmussen; Brian T DeVree; Yaozhong Zou; Andrew C Kruse; Ka Young Chung; Tong Sun Kobilka; Foon Sun Thian; Pil Seok Chae; Els Pardon; Diane Calinski; Jesper M Mathiesen; Syed T A Shah; Joseph A Lyons; Martin Caffrey; Samuel H Gellman; Jan Steyaert; Georgios Skiniotis; William I Weis; Roger K Sunahara; Brian K Kobilka
Journal:  Nature       Date:  2011-07-19       Impact factor: 49.962

Review 8.  GPCR oligomers in pharmacology and signaling.

Authors:  Javier González-Maeso
Journal:  Mol Brain       Date:  2011-05-27       Impact factor: 4.041

9.  Structure of the human κ-opioid receptor in complex with JDTic.

Authors:  Huixian Wu; Daniel Wacker; Mauro Mileni; Vsevolod Katritch; Gye Won Han; Eyal Vardy; Wei Liu; Aaron A Thompson; Xi-Ping Huang; F Ivy Carroll; S Wayne Mascarella; Richard B Westkaemper; Philip D Mosier; Bryan L Roth; Vadim Cherezov; Raymond C Stevens
Journal:  Nature       Date:  2012-03-21       Impact factor: 49.962

10.  HDAC2 regulates atypical antipsychotic responses through the modulation of mGlu2 promoter activity.

Authors:  Mitsumasa Kurita; Terrell Holloway; Aintzane García-Bea; Alexey Kozlenkov; Allyson K Friedman; José L Moreno; Mitra Heshmati; Sam A Golden; Pamela J Kennedy; Nagahide Takahashi; David M Dietz; Giuseppe Mocci; Ane M Gabilondo; James Hanks; Adrienne Umali; Luis F Callado; Amelia L Gallitano; Rachael L Neve; Li Shen; Joseph D Buxbaum; Ming-Hu Han; Eric J Nestler; J Javier Meana; Scott J Russo; Javier González-Maeso
Journal:  Nat Neurosci       Date:  2012-08-05       Impact factor: 24.884

View more
  34 in total

1.  Cross-signaling in metabotropic glutamate 2 and serotonin 2A receptor heteromers in mammalian cells.

Authors:  Lia Baki; Miguel Fribourg; Jason Younkin; Jose Miguel Eltit; Jose L Moreno; Gyu Park; Zhanna Vysotskaya; Adishesh Narahari; Stuart C Sealfon; Javier Gonzalez-Maeso; Diomedes E Logothetis
Journal:  Pflugers Arch       Date:  2016-01-16       Impact factor: 3.657

2.  Differences in 5-HT2A and mGlu2 Receptor Expression Levels and Repressive Epigenetic Modifications at the 5-HT2A Promoter Region in the Roman Low- (RLA-I) and High- (RHA-I) Avoidance Rat Strains.

Authors:  Luna Fomsgaard; Jose L Moreno; Mario de la Fuente Revenga; Tomasz Brudek; Dea Adamsen; Cristobal Rio-Alamos; Justin Saunders; Anders Bue Klein; Ignasi Oliveras; Toni Cañete; Gloria Blazquez; Adolf Tobeña; Albert Fernandez-Teruel; Javier Gonzalez-Maeso; Susana Aznar
Journal:  Mol Neurobiol       Date:  2017-03-06       Impact factor: 5.590

3.  Specific activation of mGlu2 induced IGF-1R transactivation in vitro through FAK phosphorylation.

Authors:  Yong-Jian Hu; Qian Sun; Wen-Hua Zhang; Yu-Jia Huo; Chan-Juan Xu; Jian-Feng Liu
Journal:  Acta Pharmacol Sin       Date:  2018-06-26       Impact factor: 6.150

Review 4.  Allosteric Modulation of GPCRs: New Insights and Potential Utility for Treatment of Schizophrenia and Other CNS Disorders.

Authors:  Daniel J Foster; P Jeffrey Conn
Journal:  Neuron       Date:  2017-05-03       Impact factor: 17.173

5.  Antipsychotic-induced Hdac2 transcription via NF-κB leads to synaptic and cognitive side effects.

Authors:  Daisuke Ibi; Mario de la Fuente Revenga; Nebojsa Kezunovic; Carolina Muguruza; Justin M Saunders; Supriya A Gaitonde; José L Moreno; Maryum K Ijaz; Vishaka Santosh; Alexey Kozlenkov; Terrell Holloway; Jeremy Seto; Aintzane García-Bea; Mitsumasa Kurita; Grace E Mosley; Yan Jiang; Daniel J Christoffel; Luis F Callado; Scott J Russo; Stella Dracheva; Juan F López-Giménez; Yongchao Ge; Carlos R Escalante; J Javier Meana; Schahram Akbarian; George W Huntley; Javier González-Maeso
Journal:  Nat Neurosci       Date:  2017-08-07       Impact factor: 24.884

Review 6.  Contribution of heteromerization to G protein-coupled receptor function.

Authors:  Supriya A Gaitonde; Javier González-Maeso
Journal:  Curr Opin Pharmacol       Date:  2016-11-09       Impact factor: 5.547

Review 7.  Structural and Biophysical Mechanisms of Class C G Protein-Coupled Receptor Function.

Authors:  Amr Ellaithy; Javier Gonzalez-Maeso; Diomedes A Logothetis; Joshua Levitz
Journal:  Trends Biochem Sci       Date:  2020-08-26       Impact factor: 13.807

8.  Interclass GPCR heteromerization affects localization and trafficking.

Authors:  Rudy Toneatti; Jong M Shin; Urjita H Shah; Carl R Mayer; Justin M Saunders; Miguel Fribourg; Paul T Arsenovic; William G Janssen; Stuart C Sealfon; Juan F López-Giménez; Deanna L Benson; Daniel E Conway; Javier González-Maeso
Journal:  Sci Signal       Date:  2020-10-20       Impact factor: 8.192

Review 9.  Hallucinogens and Serotonin 5-HT2A Receptor-Mediated Signaling Pathways.

Authors:  Juan F López-Giménez; Javier González-Maeso
Journal:  Curr Top Behav Neurosci       Date:  2018

10.  Reformulating a Pharmacophore for 5-HT2A Serotonin Receptor Antagonists.

Authors:  Jason Younkin; Supriya A Gaitonde; Amr Ellaithy; Rakesh Vekariya; Lia Baki; José L Moreno; Sneha Shah; Peter Drossopoulos; Kelsey S Hideshima; Jose Miguel Eltit; Javier González-Maeso; Diomedes E Logothetis; Malgorzata Dukat; Richard A Glennon
Journal:  ACS Chem Neurosci       Date:  2016-07-19       Impact factor: 4.418

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.